Roche Holding AG (RO)

334.20
-6.80(-1.99%)
  • Volume:
    45,407
  • Bid/Ask:
    334.20/334.80
  • Day's Range:
    333.60 - 340.00
Earnings results expected tomorrow

Roche Holding will announce its quarterly financial results tomorrow. Traders should take this into account as the share price often fluctuates around this time period.

1 / 2

RO Overview

Prev. Close
341
Day's Range
333.6-340
Revenue
32.09B
Open
339.6
52 wk Range
333.6-439.2
EPS
17.85
Volume
45,407
Market Cap
268.37B
Dividend (Yield)
9.30
(2.65%)
Average Volume (3m)
37,454
P/E Ratio
19.06
Beta
0.208
1-Year Change
-12.05%
Shares Outstanding
801,094,291
Next Earnings Date
02 Feb 2023
What is your sentiment on Roche Holding?
or
Market is currently closed. Voting is open during market hours.

Roche Holding AG News

Roche Holding AG Analysis

Roche Holding AG Company Profile

Roche Holding AG Company Profile

Employees
100920
  • Type:Equity
  • Market:Switzerland
  • ISIN:CH0012032113
  • S/N:1203211

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Read More

Analyst Price Target

Average355.00 (+6.22% Upside)
High355.00
Low355.00
Price334.20
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • easy:)
    0